drugset

drugset / Trial / NCT01070433

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers

NCT01070433 ↗

Phase 2 Completed 75 enrolled Skingenix, Inc.

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment of subjects with diabetic foot ulcers (DFUs).

Timeline

Start: 2012-09
Primary completion: 2013-09
Completion: 2013-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MEBO Wound Ointment	Unknown	—	Topical

Indications